Marshall partnership aimed at anti-cancer drugs


Save Story
Leer en español

Estimated read time: Less than a minute

This archived news story is available only for your personal, non-commercial use. Information in the story may be outdated or superseded by additional information. Reading or replaying the story in its archived form does not constitute a republication of the story.

HUNTINGTON, W.Va. (AP) — Marshall University is teaming up with an international biosciences company to develop potential anti-cancer drugs.

The partnership is between the Marshall Institute for Interdisciplinary Research and the Joan C. Edwards School of Medicine and Shanghai's HD Biosciences Co. Ltd. The partners will share the costs and risks of discovery and development of new drugs.

By the same token, they will jointly own any intellectual property and commercialization rights to products developed through the arrangement.

A representative with HD Biosciences says the Marshall medical school has developed viable drug candidates over the years. He said the collaboration will speed what is typically a long process and spread the costs.

Copyright © The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Most recent U.S. stories

Related topics

U.S.
The Associated Press

    STAY IN THE KNOW

    Get informative articles and interesting stories delivered to your inbox weekly. Subscribe to the KSL.com Trending 5.
    By subscribing, you acknowledge and agree to KSL.com's Terms of Use and Privacy Policy.

    KSL Weather Forecast